MedTrace Logo

Effect of Inspiratory Muscle Training in Cognition

NCT07146373 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 76

Last updated 2025-08-28

No results posted yet for this study

Summary

The goal of this clinical trial is to examine the effect of a respiratory muscle strengthening program on the cognitive and physical functioning of patients with neurocognitive disorders (Mild Cognitive Impairment) or those predisposed to them.

The main questions that aims to answer are:

1. Is Inpsiratory Muscle Training (IMT) feasible in people with mild cognitive impairement?
2. Could Inspiratory Muscle Training (IMT) improve congitive function in people with mild cognitive impairement?
3. Could Inspiratory Musclre training improve physical function in this population?

Participants will be:

1. \< 60 age or \> 90 age
2. MMSE (Mini Mental State Examination) score ≤ 28 and ≥ 18 and follow a high intensity IMT program along with a physical - cognitive program. or just the physical - cognitive program.

Conditions

  • Mild Cognitive Impairment (MCI)

Interventions

OTHER

Inspiratoty Muscle training

Participants will follow an IMT program through a threshold IMT device which consists of 5 set/6 breaths at 50-60% MIP for 3 months along with their usual physical and cogntive training

OTHER

Usual Care

Physical and cognitive training

Sponsors & Collaborators

  • University of West Attica

    lead OTHER

Principal Investigators

  • IRINI PATSAKI, PhD · University of West Attica

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
60 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2027-12-30
Completion
2028-05-30

Countries

  • Greece

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07146373 on ClinicalTrials.gov